VALLEY COTTAGE, N.Y. – A recent market study published by the company “Chemotherapy-Induced Myelosuppression Treatment Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists of a comprehensive assessment of the most important market dynamics. After conducting thorough research on the.
OncXerna Therapeutics Appoints Colleen Mockbee as Chief Development Officer and Senior Vice President of Regulatory Affairs
WALTHAM, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to potentially predict patient responses to its first-in-class targeted oncology therapies, today announced the appointment of Colleen Mockbee as Chief Development Officer and Senior Vice President of Regulatory Affairs.
“I am thrilled to reunite with Colleen and have her join our team given her deep expertise in oncology drug development,” said Laura Benjamin, Ph.D., President and Chief Executive Officer at OncXerna Therapeutics. “Her track record of success in developing and executing clinical development and regulatory strategies is impressive. This track record will be critical as we prepare to advance our navicixizumab and bavituximab programs towards registration trials using our unique RNA-base
He Was My First, Too
Essay
He Was My First, Too
I breathed a sigh of relief as I pulled into the only available spot behind the nondescript building where a therapist I’ll call Michael has his office. DC’s terrible traffic, along with the frustrating search for a parking spot, had frayed my already keyed up nervous system. A quick look in the rearview mirror told me nothing I didn’t already know. My short hair, dark on top, silver on the sides, was as neatly styled as ever. The sagging under my eyes, unfortunate evidence of my age, was almost concealed in the lift of my bright and hopeful smile. I was feeling the invisibility of age, aware that my previously reliable sexual currency had begun to lose its value.
A recent market study published by the company “Chemotherapy-Induced Myelosuppression Treatment Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists of a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as cu.